Yiling Yu

1PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 13, 2021
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia.

Gang An, Daobin Zhou, Shu Cheng

Pageof 1

Frequent Collaborators

1 joint publications

Jianfeng Zhou

1 joint publications

Jie Jin